BRIEF published on 10/01/2024 at 15:47, 2 years ago Franchissement de seuil par Mirova dans MEDINCELL Capital Franchissement De Seuil Actions Medincell Mirova
BRIEF published on 10/01/2024 at 15:47, 2 years ago Threshold crossing by Mirova in MEDINCELL Capital Actions Threshold Crossing Medincell Mirova
PRESS RELEASE published on 10/01/2024 at 15:42, 2 years ago Franchissement de seuil Déclaration de franchissement de seuil par Mirova pour le compte de fonds gérés, détenant 7,07% du capital et 5,01% des droits de vote de MEDINCELL Acquisition Franchissement De Seuil AMF Medincell Mirova
BRIEF published on 09/24/2024 at 11:54, 2 years 1 month ago Teva et Medincell Présentent des Résultats Prometteurs sur l'Olanzapine LAI pour la Schizophrénie Schizophrénie Essai Clinique Medincell Teva Olanzapine LAI
BRIEF published on 09/24/2024 at 11:54, 2 years 1 month ago Teva and Medincell Present Promising Results on Olanzapine LAI for Schizophrenia Clinical Trial Schizophrenia Medincell Teva Olanzapine LAI
PRESS RELEASE published on 09/24/2024 at 11:53, 2 years 1 month ago Inside Information / Other news releases Teva and Medincell reveal positive efficacy, safety, and tolerability data from Phase 3 study on Olanzapine LAI for schizophrenia treatment, presenting at ECNP 2024 Schizophrenia Treatment Phase 3 Study Medincell Teva Olanzapine LAI
PRESS RELEASE published on 09/24/2024 at 11:49, 2 years 1 month ago INFORMATIONS PRIVILÉGIÉES / AUTRES COMMUNIQUÉS Teva présente de nouvelles données sur l'efficacité de l'olanzapine LAI pour la schizophrénie lors de l'ENCP 2024. Collaboration Teva-Medincell pour développement Schizophrénie Efficacité Medincell Teva ENCP 2024
BRIEF published on 09/18/2024 at 10:13, 2 years 1 month ago Mirova franchit le seuil des 5% des droits de vote de MEDINCELL Droits De Vote Franchissement De Seuil Actions Medincell Mirova
BRIEF published on 09/18/2024 at 10:13, 2 years 1 month ago Mirova crosses the threshold of 5% of voting rights in MEDINCELL Voting Rights Actions Threshold Crossing Medincell Mirova
PRESS RELEASE published on 09/18/2024 at 10:08, 2 years 1 month ago Franchissement de seuil Déclaration de franchissement de seuil par Mirova pour le compte de fonds qu'elle gère concernant MEDINCELL sur Euronext Paris Euronext Paris Franchissement De Seuil Gestion Medincell Mirova
Published on 10/30/2026 at 23:35, 1 hour 41 minutes ago Prospect Ridge Announces Closing of Critical Metals Flow-through Unit Private Placement
Published on 10/30/2026 at 23:30, 1 hour 46 minutes ago Revolve Enters into Definitive Agreement to Acquire Three Project, 6 MW Battery Storage Portfolio in Ontario
Published on 10/30/2026 at 20:47, 4 hours 29 minutes ago CoTec Holdings Corp. Comments on Share Trading
Published on 10/30/2026 at 19:00, 6 hours 16 minutes ago Electric Royalties Ltd. Announces Application for Warrant Extension
Published on 10/30/2026 at 15:30, 9 hours 46 minutes ago Bluejay Diagnostics Announces 1-for-4 Reverse Stock Split
Published on 10/30/2026 at 22:49, 2 hours 27 minutes ago EQS-Adhoc: STRATEC SELLS LOSS-MAKING BUSINESS, RECOGNIZES IMPAIRMENTS, AND AMENDS GUIDANCE
Published on 10/30/2026 at 18:38, 6 hours 38 minutes ago EQS-Adhoc: Starcom Holding AD publishes Interim Q3 2026 Financial Report
Published on 10/30/2026 at 23:00, 2 hours 16 minutes ago BIOPHYTIS REPORTS FIRST- HALF 2026 RESULTS AND PROVIDES AN UPDATE ON ITS STRATEGY
Published on 10/30/2026 at 23:00, 2 hours 16 minutes ago Biophytis publie les résultats du premier semestre 2026 et fait le point sur sa stratégie
